BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16626308)

  • 1. Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer.
    Sandhu JS; Vickers AJ; Bochner B; Donat SM; Herr HW; Dalbagni G
    BJU Int; 2006 Jul; 98(1):59-62. PubMed ID: 16626308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy.
    Bostrom PJ; Soloway MS; Manoharan M; Ayyathurai R; Samavedi S
    J Urol; 2008 Jan; 179(1):91-5; discussion 95. PubMed ID: 17997457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of patients with carcinoma in situ of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Leibovich BC; Egan KS; Spotts BE; Bostwick DG
    Cancer; 1999 Jun; 85(11):2469-74. PubMed ID: 10357420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo muscle invasive bladder cancer: is there a change in trend?
    Vaidya A; Soloway MS; Hawke C; Tiguert R; Civantos F
    J Urol; 2001 Jan; 165(1):47-50; discussion 50. PubMed ID: 11125361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelial carcinoma after external beam radiation therapy for prostate cancer.
    Shah SK; Lui PD; Baldwin DD; Ruckle HC
    J Urol; 2006 Jun; 175(6):2063-6. PubMed ID: 16697804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis.
    Singh AK; Mashtare TL; McCloskey SA; Seixas-Mikelus SA; Kim HL; May KS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1086-94. PubMed ID: 20350797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology.
    Barocas DA; Patel SG; Chang SS; Clark PE; Smith JA; Cookson MS
    BJU Int; 2009 Oct; 104(8):1091-7. PubMed ID: 19389006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features.
    Vargas C; Martínez A; Galalae R; Demanes J; Harsolia A; Schour L; Nuernberg N; Gonzalez J
    Prostate Cancer Prostatic Dis; 2006; 9(3):245-53. PubMed ID: 16786040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer incidence after localized therapy for prostate cancer.
    Moon K; Stukenborg GJ; Keim J; Theodorescu D
    Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.
    Chrouser K; Leibovich B; Bergstralh E; Zincke H; Blute M
    J Urol; 2005 Jul; 174(1):107-10; discussion 110-1. PubMed ID: 15947588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy.
    Lambert EH; Pierorazio PM; Olsson CA; Benson MC; McKiernan JM; Poon S
    BJU Int; 2007 Jul; 100(1):33-6. PubMed ID: 17552951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion.
    Lee CT; Dunn RL; Ingold C; Montie JE; Wood DP
    Urology; 2007 Jun; 69(6):1068-72. PubMed ID: 17572188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
    Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
    BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.